Associate Director - Business Process Excellence
Novartis
This listing was originally posted on Novartis's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moJob Description Summary
The Associate Director, Business Process Excellence will lead strategic process simplification and re-engineering initiatives across the end-to-end drug development value chain, from Portfolio Entry to Regulatory Approval. The role is responsible for driving measurable improvements in cycle time, productivity, quality, compliance, and operational effectiveness through structured problem solving, Lean Six Sigma, Agile methodologies, and process redesign.
Job Description
Major accountabilities:
Process Re-engineering & Business Transformation
Strategic Program Leadership
o Cycle Time Acceleration Programs
o Technology Transformation (e.g., ASCEND and Digital initiatives)
o AI-enabled Productivity Programs
o Operational Excellence and Process Simplification Programs
Structured Problem Solving & Facilitation·
Stakeholder Engagement & Capability Building
Essential Requirements
Desirables Skills
Skills Desired
Clinical Research, Drug Development, Financial Management, Microsoft Project, Program Management, Project Delivery, Project Planning, Resource Allocation, Risk Management, Stakeholder Management, Waterfall ModelExplore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Novartis?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Small Molecules, Vaccines, Biologics / Diagnostics
Upgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo